Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2012
02/23/2012WO2011107881A3 Compounds, compositions, formulations and their uses in the treatment diseases related to copper retention or hepatic disorders
02/23/2012US20120046638 Method of inducing a CTL response
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046366 Extractions of Fixed Oil and Thymoquinone Rich Fractions (TQRF)
02/23/2012US20120046357 Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
02/23/2012US20120046351 Medicinal cannabis added in food
02/23/2012US20120046349 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs
02/23/2012US20120046334 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046324 Small molecule inhibitors of kynurenine-3-monooxygenase
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046315 Intermediate and oral administrative formats containing lenalidomide
02/23/2012US20120046314 Nitroxides for use in treating or preventing neoplastic disease
02/23/2012US20120046310 Compositions for delivering highly water soluble drugs
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046306 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046295 Compounds useful as inhibitors of atr kinase
02/23/2012US20120046288 Hydrazonamide Compounds That Modulate Hsp90 Activity
02/23/2012US20120046287 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046278 Thiazolopyrimidine modulators as immunosuppressive agents
02/23/2012US20120046272 Novel Therapeutic Compounds
02/23/2012US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046267 7-aminofuropyridine derivatives
02/23/2012US20120046266 Resorcinol derivatives as hsp90 inhibitors
02/23/2012US20120046265 USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER
02/23/2012US20120046262 Megestrol acetate products, method of manufacture, and method of use
02/23/2012US20120046250 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/23/2012US20120046247 1,5-diphenyl-penta-1,4-dien-3-one compounds
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators
02/23/2012US20120046242 Molecular activators of the wnt/beta-catenin pathway
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046234 Therapeutic compounds
02/23/2012US20120046233 Mutations in the lnk gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045776 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
02/23/2012US20120045766 Jarid1b for target gene of cancer therapy and diagnosis
02/23/2012US20120045755 Her-2 binding antagonists
02/23/2012US20120045532 Anticancer Methods Employing Extracts of Gleditsia sinensis Lam
02/23/2012US20120045524 Combination therapy with parp inhibitors
02/23/2012US20120045523 Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic "apoptosis" pathway in the treatment of cancer
02/23/2012US20120045520 Pharmaceutical composition comprising arsenite for the treatment of malignancy
02/23/2012US20120045519 Use of deoxyelephantopin (det) and analogues thereof for treatment of melanoma
02/23/2012US20120045516 Composition for photodynamic therapy comprising a macromolecular capsule
02/23/2012US20120045515 Hollow silica particle with a polymer thereon
02/23/2012US20120045514 Anti-cancer microparticle
02/23/2012US20120045502 Antagonists of muc1
02/23/2012US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation
02/23/2012US20120045489 Nano-Emulsion Injection of Vinca Alkaloids and the Preparation Method Thereof
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045477 Method for Treating Cancer with Toxoplasma Gondii Vaccine
02/23/2012US20120045466 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120045465 Cancer antigen helper peptide
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045450 Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
02/23/2012US20120045448 Trp-p8 active compounds and therapeutic treatment methods
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045446 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
02/23/2012US20120045444 Treatment for Neoplastic Diseases
02/23/2012US20120045442 Human monoclonal antibodies to ctla-4
02/23/2012US20120045439 Tumor markers and methods of use thereof
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF
02/23/2012US20120045436 Humanized Anti-CD70 Binding Agents and Uses Thereof
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045434 Combination therapy
02/23/2012US20120045433 Combination therapy
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045428 Methods for preparing a fermented ginseng concentrate or powder
02/23/2012US20120045425 Delta 4, 5 glycuronidase compositions and methods related thereto
02/23/2012US20120045423 Cells expressing TH1 characteristics and cytolytic properties
02/23/2012US20120045414 Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity
02/23/2012US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts
02/23/2012US20120045412 Cycloalkylidene and heterocycloalkylidene inhibitor compounds
02/23/2012US20120045411 Short beta-defensin-derived peptides
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045393 Lhrh-ii peptide analogs
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives
02/23/2012CA2844109A1 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012CA2841217A1 Novel sulfonamide compounds for inhibition of metastatic tumor growth
02/23/2012CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012CA2808744A1 Combined use of fc gamma riib (cd32b) and cd20 specific antibodies
02/23/2012CA2808679A1 Novel phytochemicals from extracts of maple syrups and maple trees and uses thereof
02/23/2012CA2808626A1 Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
02/23/2012CA2808624A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2808540A1 Pyrimidine derivatives as fak inhibitors
1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 2211